HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Possibility of selective binding of HIV-1 infected cells by immunosorbents].

Abstract
A study was made of a possibility of specific sorption of HIV-1 infected cells with gamma-fraction of AIDS patients' serum containing high titer-specific antibodies, immobilized on the silica matrix (C-3). The laboratory tests were made with the use of the monocyte culture [symbol: see text] chronically infected with HIV-1. In addition to a decrease of the cell count after sorption, there was a decline of the activity of antigen material in the samples (to 43% of the initial). The selectivity rates were 0.92 for immunosorbents and 0.29 for sorbents of the control group, that confirms and increase of the delay of the cells expressing HIV-1 proteins on a column with the immobilized gamma-fraction of AIDS patients' serum. The use of the synthesized immunosorbents in vivo may appear debatable. However, this method can be employed for preparative purposes.
AuthorsIu M Lopukhin, V V Pavlenko, D V Kulaev, V S Alekseĭchuk, E V Karamov, I A Rudneva, D D Petrunin, T K Liukova
JournalVestnik Rossiiskoi akademii meditsinskikh nauk (Vestn Ross Akad Med Nauk) Issue 3 Pg. 54-6 ( 1992) ISSN: 0869-6047 [Print] Russia (Federation)
Vernacular TitleIzuchenie vozmozhnosti selektivnogo sviazyvaniia infitsirovannykh VICh-1 kletok s pomoshch'iu immunosorbentov.
PMID1382761 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • HIV Antibodies
  • Immunosorbents
  • Viral Proteins
Topics
  • Acquired Immunodeficiency Syndrome (immunology, metabolism)
  • Cell Count
  • Cells, Cultured
  • Enzyme-Linked Immunosorbent Assay
  • Fluorescent Antibody Technique
  • HIV Antibodies (analysis)
  • HIV-1 (immunology, metabolism)
  • Humans
  • Immunosorbents
  • Viral Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: